Please assess the completion status of the following clinical trial:

Trial Title: Sodium Citrate 4% Locking Solution for Children Requiring Home Parenteral Nutrition

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Pediatric patients (\<18 years) and adult patients (up to 21 years still in our clinic)~* requiring long-term (\>3 months) home parenteral nutrition due to intestinal failure/short bowel syndrome~* has had at least one central line-associated blood stream infection~Exclusion Criteria:~* known cardiac arrhythmias~* hypersensitivity to citrate~* pregnancy~* receiving continuous parenteral nutrition (infusing over 24 hours)

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Sodium citrate 4% (Type: EXPERIMENTAL): All enrolled participants will received the daily sodium citrate 4% locking solution for CLABSI prophylaxis intervention and be observed prospectively for adverse events

Based on this trial design, predict the completion outcome and termination type (if applicable).